Recent Updates
  • Biostimulants Market Size, Share, Growth Factors, Competitive Landscape, with Regional Forecast to 2035
    The Global Biostimulants Market Report is a comprehensive report on the Biostimulants market, offering key insights on business strategies, current trends, and presenting qualitative and quantitative analysis of the Biostimulants market. This report offers in-depth research insights on key and significant aspects of the Biostimulants market, providing an in-depth analysis of key drivers,...
    0 Comments 0 Shares 904 Views 0 Reviews
  • Companion Diagnostics Market Size, Share, Growth Factors, Competitive Landscape, with Regional Forecast to 2035
    The Global Companion Diagnostics Market Report is a comprehensive report on the Companion Diagnostics market, offering key insights on business strategies, current trends, and presenting qualitative and quantitative analysis of the Companion Diagnostics market. This report offers in-depth research insights on key and significant aspects of the Companion Diagnostics market, providing an in-depth...
    0 Comments 0 Shares 704 Views 0 Reviews
  • Real World Evidence Solutions Market Size, Share, Emerging Factors, Trends, Segmentation and Forecast to 2035
    The latest report published by Roots Analysis, titled Real World Evidence Solutions Market offers a detailed study of the industry size, growth scenarios, and fundamental parameters of the market analysis. In this research report, the author provided an in-depth analysis of market dynamics, including key drivers, restraints, opportunities, and major threats that may impact growth during the...
    0 Comments 0 Shares 901 Views 0 Reviews
  • PARP Inhibitors Market Estimated to Experience a Hike in Growth by 2035
    The new market report titled ‘PARP Inhibitors Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the PARP Inhibitors Market. The PARP inhibitors market is estimated to be worth $8 billion in 2030 and is expected to grow at CAGR of 18% during the forecast period. The report will help readers stay updated with the latest market...
    0 Comments 0 Shares 767 Views 0 Reviews
  • Cold Chain Logistics Market - Current Impact to Make Big Changes by 2035
    Global Cold Chain Logistics Market survey report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of healthcare industry. The most up to date market insights and analysis performed in this business report brings marketplace clearly into focus. This market research study analyses the market status,...
    0 Comments 0 Shares 781 Views 0 Reviews
  • Anti-Aging Drugs Market Report by Worldwide Market Trends & Opportunities and Forecast to 2035
    The latest report entitled ‘Anti Aging Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The anti aging market is estimated to grow from $79 million in 2025 to $3,368 million in 2040, growing at a CAGR of 27% during the forecast period 2025 - 2040. The report turns the...
    0 Comments 0 Shares 862 Views 0 Reviews
  • Online Trading Platform Market Extensive Industry Analysis, Growth Rate, Segmentation, Investment Opportunities and Top Manufacturers 2035
    The Global Online Trading Platform Market Report is a comprehensive report on the Online Trading Platform market, offering key insights on business strategies, current trends, and presenting qualitative and quantitative analysis of the Online Trading Platform market. This report offers in-depth research insights on key and significant aspects of the Online Trading Platform market, providing an...
    0 Comments 0 Shares 819 Views 0 Reviews
  • Video Conferencing Market Extensive Industry Analysis, Growth Rate, Segmentation, Investment Opportunities and Top Manufacturers 2035
    The Global Video Conferencing Market Report is a comprehensive report on the Video Conferencing market, offering key insights on business strategies, current trends, and presenting qualitative and quantitative analysis of the Video Conferencing market. This report offers in-depth research insights on key and significant aspects of the Video Conferencing market, providing an in-depth analysis of...
    0 Comments 0 Shares 743 Views 0 Reviews
  • Gene therapy Market Comprehensive Statistics, Growth Rate, and Future Trends 2035
    The global gene therapy market is estimated to grow from $2.4 billion in 2024 to $16.5 billion by 2035, representing a CAGR of 19.25% during the forecast period till 2035. In recent years, gene therapy has been demonstrated to be a promising solution for patients suffering from severe inherited disorders. These therapies have shown remarkable outcomes in enhancing the life expectancy of...
    0 Comments 0 Shares 839 Views 0 Reviews
  • Flow Cytometry Market Growth and Status Explored in a New Research Report 2035
    The new market report titled ‘Flow Cytometry Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the Flow Cytometry Market.   The global flow cytometry market size is valued at USD 5.1 billion in 2024 and is poised to reach USD 10.75 billion in 2032, representing a CAGR of 8.25% during the forecast period. The report...
    0 Comments 0 Shares 798 Views 0 Reviews
  • Probiotics Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035

    The market opportunity associated Probiotics Market is anticipated to witness a CAGR of 8.0% over the next decade. The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035.
    Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies.
    It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period.
    Furthermore, the global market opportunity is expected to be well-distributed across different market segmentations, including different food and beverage products, food and beverages, ingredients, end user and distribution channels. Presently, the probiotics for humans capture the highest probiotics market share and are likely to remain the same during the forecast period.
    In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel probiotics that can be consumed by various human population
    The primary purpose of this analysis was to develop a better understanding of the overall potential and capabilities of different companies having probiotic portfolio. It is worth highlighting that the input data used for this analysis was collated from publicly available sources. Further, at no point should the inferences presented in this section be construed as a recommendation that one company is better than another.
    The following approach was adopted to compare the key probiotic companies in the market:
    • As a starting point, we collated information on the aforementioned parameters for key companies that are involved in the offering probiotics, and thus, were considered for this analysis.
    • The probiotic companies were segregated across three peer groups based on their company size, including mid-sized, large and very large companies.
    Further, company competitiveness was assessed score for companies using company strength (in terms of number of years since its establishment) and portfolio strength (based on number of probiotic brands, type of probiotic, target human population, end user and type of ingredient).
    More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field.
    Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics.
    During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation.
    Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/probiotics-market.html


    Probiotics Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035 The market opportunity associated Probiotics Market is anticipated to witness a CAGR of 8.0% over the next decade. The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035. Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies. It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period. Furthermore, the global market opportunity is expected to be well-distributed across different market segmentations, including different food and beverage products, food and beverages, ingredients, end user and distribution channels. Presently, the probiotics for humans capture the highest probiotics market share and are likely to remain the same during the forecast period. In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel probiotics that can be consumed by various human population The primary purpose of this analysis was to develop a better understanding of the overall potential and capabilities of different companies having probiotic portfolio. It is worth highlighting that the input data used for this analysis was collated from publicly available sources. Further, at no point should the inferences presented in this section be construed as a recommendation that one company is better than another. The following approach was adopted to compare the key probiotic companies in the market: • As a starting point, we collated information on the aforementioned parameters for key companies that are involved in the offering probiotics, and thus, were considered for this analysis. • The probiotic companies were segregated across three peer groups based on their company size, including mid-sized, large and very large companies. Further, company competitiveness was assessed score for companies using company strength (in terms of number of years since its establishment) and portfolio strength (based on number of probiotic brands, type of probiotic, target human population, end user and type of ingredient). More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field. Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics. During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/probiotics-market.html
    WWW.ROOTSANALYSIS.COM
    Probiotics Market Size, Share & Growth, Trends Analysis Report [2035]
    The global probiotics market is estimated to grow from $70.9 billion in 2024 to $165.1 billion by 2035, at a CAGR of 8.0% during the forecast period, till 2035.
    0 Comments 0 Shares 2K Views 0 Reviews
  • RNA Therapeutics Market Growth and Status Explored in a New Research Report 2035

    Owing to their clinical potential to specifically target and treat various disease indications, the next generation RNA therapeutics and vaccines have gained significant traction and are anticipated to revolutionize the healthcare and medical sector.


    The global RNA therapeutics and vaccines market size is estimated to grow from USD 1.2 million in 2023 to USD 948 million by 2035, representing a CAGR of 68% during the forecast period 2023-2035.

    Over the years, RNA-based therapeutics and vaccines have been studied extensively for their crucial role in gene function and protein expression regulation. Owing to their vast potential in the treatment of a myriad of disease indications, targeting previously deemed undruggable targets, and high therapeutic efficiency, these molecules have transitioned into a compelling treatment alternative for a range of disorders. However, a major challenge in the implementation of these therapies lies in the highly unstable structure of the RNA molecule. The loose prime terminals of RNA molecules allow quick degradation of these molecules by restriction exonucleases. In recent years, the advent of advanced technologies and platforms has escalated the interest of industry stakeholders towards enhanced and modified RNA-based therapies, that are believed to be highly stable and have an extended impact at relatively low doses.

    The types of next generation RNA therapeutics and RNA vaccines include circular RNA (circRNA), endless RNA (eRNA), self activating RNA (sacRNA), self amplifying RNA (saRNA), self amplifying mRNA (samRNA), replicating RNA (repRNA) and transfer RNA (tRNA). The success of these next generation RNA therapeutics and RNA vaccines can be attributed to their structural stability, expression specificity, targeted delivery, non-immunogenic nature, high efficiency and ability to target a wide range of therapeutic modalities, including influenza, COVID-19 infection, breast cancer and interstitial lung disease, among others.

    Next generation RNA therapeutics and RNA vaccines offer great promise in the healthcare sector, as a result of which, various drug and technology developers are shifting their focus towards the design, development, manufacturing and delivery of these innovative modalities.

    Given the ongoing pace of innovation in this field, encouraging clinical trial results, accelerated approvals, and the continuous efforts of both industry and non-industry players, the next generation RNA vaccines and RNA therapeutics market is likely to witness significant growth during the forecast period.

    Over 35 next generation RNA technologies are being developed / offered by companies for the research, discovery, design, development, manufacturing and delivery of novel rna therapies and vaccines.
    Currently, over 35 next generation RNA technologies are being developed / offered by industry players. It is worth mentioning that most of the technologies are being deployed for next generation RNA based therapeutics. Examples of technologies used in the development of both self-amplifying RNA therapeutics and vaccines include ChaESAR Technology and VaxEquity’s Next-generation RNA Platform.

    The number and geographical distribution of clinical trials are important indicators of both the therapeutic viability and future potential of innovative pharmacological interventions. Over the years, several pharmaceutical / biopharmaceutical companies have conducted extensive clinical studies for only those drug / therapy classes that are likely to translate into commercial success. Moreover, the geographical distribution directly indicates the various markets that are open to receiving / adopting the intervention under investigation. As more product candidates get approved by the regulatory authorities across the globe, the number of clinical trials across different global regions is anticipated to increase.

    There was a steady increase in the number of clinical trials registered for the evaluation of next generation RNA therapeutics and vaccines, during the period 2019-2023. This increase can be attributed to the incessant efforts of several industry / non-industry players that are actively developing and testing different types of novel RNA-based approaches for the treatment of a wide range of disorders. It is also worth highlighting that, over the years, most of the trials (33%) were registered in 2022.
    Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/rna-therapeutics-market.html

    RNA Therapeutics Market Growth and Status Explored in a New Research Report 2035 Owing to their clinical potential to specifically target and treat various disease indications, the next generation RNA therapeutics and vaccines have gained significant traction and are anticipated to revolutionize the healthcare and medical sector. The global RNA therapeutics and vaccines market size is estimated to grow from USD 1.2 million in 2023 to USD 948 million by 2035, representing a CAGR of 68% during the forecast period 2023-2035. Over the years, RNA-based therapeutics and vaccines have been studied extensively for their crucial role in gene function and protein expression regulation. Owing to their vast potential in the treatment of a myriad of disease indications, targeting previously deemed undruggable targets, and high therapeutic efficiency, these molecules have transitioned into a compelling treatment alternative for a range of disorders. However, a major challenge in the implementation of these therapies lies in the highly unstable structure of the RNA molecule. The loose prime terminals of RNA molecules allow quick degradation of these molecules by restriction exonucleases. In recent years, the advent of advanced technologies and platforms has escalated the interest of industry stakeholders towards enhanced and modified RNA-based therapies, that are believed to be highly stable and have an extended impact at relatively low doses. The types of next generation RNA therapeutics and RNA vaccines include circular RNA (circRNA), endless RNA (eRNA), self activating RNA (sacRNA), self amplifying RNA (saRNA), self amplifying mRNA (samRNA), replicating RNA (repRNA) and transfer RNA (tRNA). The success of these next generation RNA therapeutics and RNA vaccines can be attributed to their structural stability, expression specificity, targeted delivery, non-immunogenic nature, high efficiency and ability to target a wide range of therapeutic modalities, including influenza, COVID-19 infection, breast cancer and interstitial lung disease, among others. Next generation RNA therapeutics and RNA vaccines offer great promise in the healthcare sector, as a result of which, various drug and technology developers are shifting their focus towards the design, development, manufacturing and delivery of these innovative modalities. Given the ongoing pace of innovation in this field, encouraging clinical trial results, accelerated approvals, and the continuous efforts of both industry and non-industry players, the next generation RNA vaccines and RNA therapeutics market is likely to witness significant growth during the forecast period. Over 35 next generation RNA technologies are being developed / offered by companies for the research, discovery, design, development, manufacturing and delivery of novel rna therapies and vaccines. Currently, over 35 next generation RNA technologies are being developed / offered by industry players. It is worth mentioning that most of the technologies are being deployed for next generation RNA based therapeutics. Examples of technologies used in the development of both self-amplifying RNA therapeutics and vaccines include ChaESAR Technology and VaxEquity’s Next-generation RNA Platform. The number and geographical distribution of clinical trials are important indicators of both the therapeutic viability and future potential of innovative pharmacological interventions. Over the years, several pharmaceutical / biopharmaceutical companies have conducted extensive clinical studies for only those drug / therapy classes that are likely to translate into commercial success. Moreover, the geographical distribution directly indicates the various markets that are open to receiving / adopting the intervention under investigation. As more product candidates get approved by the regulatory authorities across the globe, the number of clinical trials across different global regions is anticipated to increase. There was a steady increase in the number of clinical trials registered for the evaluation of next generation RNA therapeutics and vaccines, during the period 2019-2023. This increase can be attributed to the incessant efforts of several industry / non-industry players that are actively developing and testing different types of novel RNA-based approaches for the treatment of a wide range of disorders. It is also worth highlighting that, over the years, most of the trials (33%) were registered in 2022. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/rna-therapeutics-market.html
    WWW.ROOTSANALYSIS.COM
    RNA Therapeutics Market Size, Share, Analysis & Forecast 2035
    The global RNA therapeutics and vaccines market size is estimated to grow from USD 1.2 million in 2023 to USD 948 million by 2035, representing a CAGR of 68% during the forecast period 2023-2035.
    0 Comments 0 Shares 2K Views 0 Reviews
  • Liquid Biopsy Market Market to Witness Promising Growth Opportunities by 2024-2035
    Global Liquid Biopsy Market survey report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of healthcare industry.   The most up to date market insights and analysis performed in this business report brings marketplace clearly into focus. This market research study analyses the market status,...
    0 Comments 0 Shares 871 Views 0 Reviews
  • Molecular Diagnostics Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035
    Molecular diagnostics aids in early detection of diseases by utilizing the genetic information of a patient in order to facilitate therapeutic monitoring and improve the overall patient healthcare outcome. The global molecular diagnostics market size is estimated to grow from $15.9 billion in 2024 to $30.9 billion by 2035, at a CAGR of 6.2% during the forecast period, till 2035. Molecular...
    0 Comments 0 Shares 863 Views 0 Reviews
  • Plant-based meat Market Key Highlights and Future Opportunities Till 2035
    Meat is an important source of macronutrients and micronutrients, such as proteins, fats, carbohydrates, and vitamins that provide the ability to build and repair tissues as well as fulfill energy requirements. Given its several pre-requisites, the demand for meat is significantly increasing, which has led to a three-fold increase in industrial meat production. However, the approach of...
    0 Comments 0 Shares 732 Views 0 Reviews
  • Medical Aesthetics Market - Current Impact to Make Big Changes by 2035

    During our research, we identified over 200 medical aesthetic companies offering various medical aesthetic products and / or devices. The global medical aesthetics market size is estimated to grow from USD 38 billion in 2024 to USD 102 billion by 2035, representing a CAGR of 9.5% during the forecast period till 2035.

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/medical-aesthetics-market.html

    Medical Aesthetics Market - Current Impact to Make Big Changes by 2035 During our research, we identified over 200 medical aesthetic companies offering various medical aesthetic products and / or devices. The global medical aesthetics market size is estimated to grow from USD 38 billion in 2024 to USD 102 billion by 2035, representing a CAGR of 9.5% during the forecast period till 2035. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/medical-aesthetics-market.html
    WWW.ROOTSANALYSIS.COM
    Medical Aesthetics Market Size, Share, Trends, Industry Report [2035]
    The global medical aesthetics market size is estimated to grow from USD 38 billion in 2024 to USD 102 billion by 2035, representing a CAGR of 9.5% during the forecast period till 2035.
    0 Comments 0 Shares 657 Views 0 Reviews
  • Human Microbiome Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035
    The latest drafted document on the global Human Microbiome Market by Roots Analysis, provides a brief discussion on industry size, current growth scenario and future opportunities. The latest drafted document on the global Human Microbiome Market by Roots Analysis, provides a brief discussion on industry size, current growth scenario and future opportunities.   In the market study...
    0 Comments 0 Shares 1K Views 0 Reviews
  • Continuous Bioprocessing Market Report by Worldwide Market Trends & Opportunities and Forecast to 2035
    In this research report, the author provided an in-depth analysis of market dynamics, including key drivers, restraints, opportunities, and major threats that may impact growth during the upcoming years.   The latest report published by Roots Analysis, titled Continuous Bioprocessing Market offers a detailed study of the industry size, growth scenarios, and fundamental parameters of the...
    0 Comments 0 Shares 1K Views 0 Reviews
  • mRNA Vaccine and Therapeutics Market Growth and Status Explored in a New Research Report 2035
    The global mRNA therapeutics and mRNA vaccine market is witnessing steady growth, estimated to be worth USD 51.3 billion in 2023. In recent years, the mRNA vaccine and therapeutics market has grown significantly, driven by increasing demand for targeted therapies to treat diseases that are difficult to address with conventional drugs. Messenger RNA (mRNA), a single-stranded ribonucleic acid...
    0 Comments 0 Shares 1K Views 0 Reviews
  • Cell Therapy Manufacturing Market Comprehensive Statistics, Growth Rate, and Future Trends 2035
    Cell Therapy Manufacturing Market Forecast to 2024-2035 The Global Cell Therapy Manufacturing Market report provides a detailed analysis of the Cell Therapy Manufacturing market, highlighting key business strategies, current trends, and both qualitative and quantitative data.   It explores important factors affecting the market, such as drivers, challenges, growth opportunities, and...
    0 Comments 0 Shares 1K Views 0 Reviews
More Stories